TG테라퓨틱스사 (TGTX)

Apr 30, 2026

Executive pay, auditor and board up for votes at TG Therapeutics (TGTX) 2026 meeting - Stock Titan

Apr 30, 2026

Apr 30, 2026

TG Therapeutics schedules Q1 results call, 2026 outlook for May 6 - Stock Titan

Apr 30, 2026

Apr 30, 2026

Pictet Asset Management Holding SA Trims Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat

Apr 30, 2026

Apr 29, 2026

Vanguard Portfolio Management discloses 5.26% stake in TG Therapeutics (NASDAQ: TGTX) - Stock Titan

Apr 29, 2026

Apr 28, 2026

TG Therapeutics Inc (TGTX) News, Articles, Events & Latest Updates - Stocktwits

Apr 28, 2026

Apr 27, 2026

TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Apr 27, 2026

Apr 27, 2026

TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance

Apr 27, 2026

Apr 27, 2026

TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M - MSN

Apr 27, 2026

Apr 27, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 21.71% Upside Potential in the Biotech Space - DirectorsTalk Interviews

Apr 27, 2026

Apr 27, 2026

TGTX completes enrollment in Phase III study on subcutaneous Briumvi - MSN

Apr 27, 2026

Apr 25, 2026

TG Therapeutics (TGTX) Is Up 7.6% After Advancing Subcutaneous BRIUMVI Phase 3 Trial Enrollment Completion - Sahm

Apr 25, 2026

Apr 24, 2026

TGTX Forecast, Price Target & Analyst Ratings | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill

Apr 24, 2026

Apr 23, 2026

(TGTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Apr 23, 2026

Apr 23, 2026

TG Therapeutics Inc. (TGTX) posts 87.3 percent year over year revenue growth despite large Q4 2025 earnings miss. - Xã Thanh Hà

Apr 23, 2026

Apr 22, 2026

Q1 EPS Estimates for TG Therapeutics Cut by HC Wainwright - MarketBeat

Apr 22, 2026

Apr 22, 2026

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting - ChartMill

Apr 22, 2026

Apr 21, 2026

TGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026

Apr 21, 2026

TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance - MSN

Apr 21, 2026

Apr 21, 2026

HC Wainwright Forecasts Lower Earnings for TG Therapeutics - MarketBeat

Apr 21, 2026

Apr 20, 2026

TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside - ChartMill

Apr 20, 2026

Apr 20, 2026

TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill

Apr 20, 2026

Apr 18, 2026

TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX) - Seeking Alpha

Apr 18, 2026

Apr 18, 2026

A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Apr 18, 2026

Apr 18, 2026

Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings? - Sahm

Apr 18, 2026

Apr 16, 2026

Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $40 - Moomoo

Apr 16, 2026

Apr 16, 2026

TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - The Globe and Mail

Apr 16, 2026

Apr 16, 2026

TG Therapeutics concludes enrolment in Phase III Briumvi trial - Yahoo Finance

Apr 16, 2026

Apr 15, 2026

TG Therapeutics Completes Enrollment for Phase 3 Multiple Sclerosis Trial - Moomoo

Apr 15, 2026

Apr 15, 2026

TG Therapeutics (TGTX) Stock Competitive Analysis (Marginal Gain) 2026-04-15Gap Down Stocks - Xã Thanh Hà

Apr 15, 2026

Apr 15, 2026

TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial By Investing.com - Investing.com Australia

Apr 15, 2026

Apr 15, 2026

TGTX Advances with Phase 3 Trial Completion for Briumvi Treatment - GuruFocus

Apr 15, 2026

Apr 15, 2026

TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial - Investing.com

Apr 15, 2026

Apr 15, 2026

MS trial completion moves TG closer to at-home BRIUMVI option - Stock Titan

Apr 15, 2026

Apr 13, 2026

Update Report: Should you avoid TG Therapeutics Inc stock right now2026 Fed Impact & Weekly Return Optimization Plans - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Price-Driven Insight from (TGTX) for Rule-Based Strategy - Stock Traders Daily

Apr 12, 2026

Apr 10, 2026

TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN

Apr 10, 2026

Apr 09, 2026

Fed Watch: Does TG Therapeutics Inc stock benefit from AI growth2026 Trade Ideas & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Gains Recap: Is TG Therapeutics Inc a turnaround storyQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada

Apr 08, 2026

Apr 08, 2026

BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $15 - Moomoo

Apr 08, 2026

Apr 07, 2026

Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn

Apr 07, 2026

Apr 05, 2026

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 05, 2026

Apr 04, 2026

TGTX PE Ratio & Valuation, Is TGTX Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill

Apr 04, 2026

Apr 04, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK

Apr 04, 2026

Apr 03, 2026

TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 02, 2026

TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 01, 2026

(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 01, 2026

Mar 31, 2026

TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha

Mar 31, 2026